Biohaven Pharmaceuticals
Biohaven Pharmaceuticals

Biohaven is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders. Biohaven has licensed intellectual property from companies and institutions including Bristol-Myers Squibb Company, AstraZeneca AB, Yale University, Catalent, ALS Biopharma LLC and Massachusetts General Hospital. Biohaven is a company organized under the laws of the British Virgin Islands and its United States operations are based in New Haven, Connecticut.
New Haven, CT, USA
Founded in 2014
biohavenpharma.com
Inaccurate data? Flag it here.
Open jobs at Biohaven Pharmaceuticals